BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,183,360 | -7.6% | 91,020 | +23.8% | 0.47% | +129.3% |
Q3 2021 | $3,446,000 | -21.9% | 73,500 | +1.5% | 0.20% | -41.1% |
Q2 2021 | $4,413,000 | -7.4% | 72,400 | -6.5% | 0.35% | -15.9% |
Q1 2021 | $4,767,000 | -5.3% | 77,400 | +9.3% | 0.41% | +5.1% |
Q4 2020 | $5,035,000 | +114.7% | 70,800 | +13.3% | 0.39% | +105.2% |
Q3 2020 | $2,345,000 | -31.4% | 62,500 | -40.4% | 0.19% | -56.6% |
Q2 2020 | $3,417,000 | +7.6% | 104,800 | -4.3% | 0.44% | -27.4% |
Q1 2020 | $3,176,000 | +220.5% | 109,500 | +286.9% | 0.61% | +218.8% |
Q4 2019 | $991,000 | – | 28,300 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |